Jacob Grønnegaard of FujiFilm Diosynth Biotechnologies discussed how the company’s unique cloning processes dramatically reduce project execution time, effort and expense at Emerson Exchange Immerse event. The result is intended to be one of the top medicine production facilities in the country. Hopefully, it won’t have to ramp up production for a virus vaccine to combat a worldwide pandemic, but if the time ever comes again, it will be scalable and ready.
Latest News
Emerson Announces Sale of Remaining Interests in Copeland to Blackstone
Emerson announced today that it has entered into a definitive agreement to sell its remaining interests in the Copeland joint venture (formerly...
Emerson to Sponsor NAMUR Annual General Meeting
Boundless Automation theme highlights next-generation automation architecture that enables improved data utilization and operating performance
Emerson’s New Laser Welder Automates Assembly of Small Plastic Parts with Complex Geometries
Branson GLX-1 platform offers automation-friendly solution for clean, vibration-free welding that supports closed-loop product recycling
